相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in rats
Mahmoud E. Youssef et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2022)
Simple Predictors for Cardiac Fibrosis in Patients with Type 2 Diabetes Mellitus: The Role of Circulating Biomarkers and Pulse Wave Velocity
Ekaterina B. Luneva et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Anti-Inflammatory Effects of Melatonin in Rats with Induced Type 2 Diabetes Mellitus
Hande Yapislar et al.
LIFE-BASEL (2022)
The role of interleukin-1β in type 2 diabetes mellitus: A systematic review and meta-analysis
Hend Alfadul et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease
Xiaomeng Feng et al.
BMC ENDOCRINE DISORDERS (2021)
Artemisinin Improves Acetylcholine-Induced Vasodilatation in Rats with Primary Hypertension
Xuanxuan Liu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
The effect of Diplotaenia turcica root extract in streptozotocin-induced diabetic rats
Ugur Ozdek et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI (2020)
Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
Jierong Luo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease
Ming Xia et al.
FRONTIERS IN PHARMACOLOGY (2020)
Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice
Wei Fu et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Protective effects of AS-IV on diabetic cardiomyopathy by improving myocardial lipid metabolism in rat models of T2DM
Zhongyuan Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases
Mehdi Sharifi-Rad et al.
FRONTIERS IN PHYSIOLOGY (2020)
Artemisinin attenuates early renal damage on diabetic nephropathy rats through suppressing TGF-beta 1 regulator and activating the Nrf2 signaling pathway
Haishan Zhang et al.
LIFE SCIENCES (2020)
The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus
Ya-yi Jiang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Transcription profiling of artemisinin-treated diabetic nephropathy rats using high-throughput sequencing
Min Xiang et al.
LIFE SCIENCES (2019)
Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy
Osama Y. Althunibat et al.
LIFE SCIENCES (2019)
A bioartificial rat heart tissue: Perfusion decellularization and characterization
Busra Ozlu et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2019)
Curcumin exerts beneficial role on insulin resistance through modulation of SOCS3 and Rac-1 pathways in type 2 diabetic rats
Zahra Zaheri et al.
JOURNAL OF FUNCTIONAL FOODS (2019)
Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
Amir M. Al Hroob et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy
Fabrizio R. Assis et al.
HEART RHYTHM (2019)
Advanced glycation end-products induce oxidative stress through the Sirt1/Nrf2 axis by interacting with the receptor of AGEsunder diabetic conditions
Xiao-Jun Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Cinnamaldehyde ameliorates STZ-induced rat diabetes through modulation of IRS1/PI3K/AKT2 pathway and AGEs/RAGE interaction
Marwa E. Abdelmageed et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Guanghong Jia et al.
CIRCULATION RESEARCH (2018)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
The Role of Advanced Glycation End Products in Diabetic Vascular Complications
Sang Youl Rhee et al.
DIABETES & METABOLISM JOURNAL (2018)
Gallic acid protects against bisphenol A-induced alterations in the cardiorenal system of Wistar rats through the antioxidant defense mechanism
Olufunke E. Ola-Davies et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
Guanghong Jia et al.
DIABETOLOGIA (2018)
The pharmacological activities and mechanisms of artemisinin and its derivatives: a systematic review
Yi-Fei Dai et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
Role of artesunate in TGF-ß1-induced renal tubular epithelial-mesenchymal transdifferentiation in NRK-52E cells
Yaqian Zhang et al.
MOLECULAR MEDICINE REPORTS (2017)
Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD
Masayoshi Takeuchi et al.
NUTRIENTS (2017)
A common base method for analysis of qPCR data and the application of simple blocking in qPCR experiments
Michael T. Ganger et al.
BMC BIOINFORMATICS (2017)
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity
Jin Li et al.
CELL (2017)
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Guanghong Jia et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats
Jun Hou et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice
Kyung Eun Kim et al.
JOURNAL OF MEDICINAL FOOD (2016)
A therapeutic cancer vaccine against GL261 murine glioma
Mark S. Kindy et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats
Nouf M. Al-Rasheed et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study
Mariana Lazo et al.
AMERICAN HEART JOURNAL (2015)
HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells
Meichu Cheng et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE
Takanori Matsui et al.
CARDIOVASCULAR DIABETOLOGY (2015)
An evaluation of the protective role of Ficus racemosa Linn. in streptozotocin-induced diabetic neuropathy with neurodegeneration
Nilay D. Solanki et al.
INDIAN JOURNAL OF PHARMACOLOGY (2015)
Role of AGEs-RAGE System in Cardiovascular Disease
Kei Fukami et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Advanced glycation end products: role in pathology of diabetic cardiomyopathy
Vijaya Lakshmi Bodiga et al.
HEART FAILURE REVIEWS (2014)
Inhibition of high-mobility group box 1 improvesmyocardial fibrosis and dysfunction in diabetic cardiomyopathy
Wen-ke Wang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway
Wen-Ke Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage
Quan Liu et al.
JOURNAL OF DIABETES INVESTIGATION (2014)
Glutathione and mitochondria
Vicent Ribas et al.
FRONTIERS IN PHARMACOLOGY (2014)
Western blot: Technique, theory and trouble shooting
Zhi-Qiang Liu et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2014)
Diabetes Mellitus and Inflammation
Eric Lontchi-Yimagou et al.
CURRENT DIABETES REPORTS (2013)
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment
Ines Falcao-Pires et al.
HEART FAILURE REVIEWS (2012)
Artemisinin suppresses sympathetic hyperinnervation following myocardial infarction via anti-inflammatory effects
Yongwei Gu et al.
JOURNAL OF MOLECULAR HISTOLOGY (2012)
TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model
Yun Ti et al.
DIABETES (2011)
Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport
Kazuaki Ohtsubo et al.
NATURE MEDICINE (2011)
Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling
Zhaojun Xiong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiornyopathy in insulin resistance type 2 diabetes mellitus rats
Ashish Kumar Sharma et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Investigation Into the Cardiac Effects of Spironolactone in the Experimental Model of Type 1 Diabetes
Bhoomika R. Goyal et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Advanced glycation end-products: a review
R Singh et al.
DIABETOLOGIA (2001)
分享论文
